Astrazeneca Pharma India informs about trading window closure

12 Dec 2024 Evaluate
Astrazeneca Pharma India has informed that in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with AstraZeneca Pharma India - Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares of the Company will be closed from December 16, 2024 and the same shall reopen after 48 hours from the declaration of un-audited financial results of the Company for the quarter ending December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8252.25 2.55 (0.03%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×